Response to comment on ‘KRAS-mutated plasma DNA as predictor of outcome from irinotecan monotherapy in metastatic colorectal cancer’

被引：0
|
作者：
K-L G Spindler
N Pallisgaard
R F Andersen
A Jakobsen
机构：
[1] Vejle Hospital,Department of Oncology
[2] Danish Colorectal Cancer Group South,Department of Biochemistry
[3] Vejle Hospital,undefined
[4] Kabbeltoft 25,undefined
[5] Vejle Hospital,undefined
[6] Current address: Department of Oncology,undefined
[7] Aarhus University Hospital,undefined
[8] Aarhus,undefined
[9] Denmark,undefined
来源：
British Journal of Cancer | 2014年 / 111卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：2380 / 2380
相关论文
共 50 条
  • [41] Treatment monitoring of metastatic colorectal cancer by quantification and genotyping of mutated KRAS in circulating cell-free DNA.
    Seufferlein, Thomas
    Schwerdel, Daniel
    Welz, Hanna
    Marienfeld, Ralf
    Schmidt, Stefan A.
    Kleger, Alexander
    Enrich, Thomas Jens
    Berger, Andreas W.
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
  • [42] Dynamics and characteristics of KRAS mutated circulating tumor DNA in patients with metastatic colorectal cancer during various treatments.
    Takayama, Yuji
    Suzuki, Koichi
    Ichida, Kosuke
    Fukui, Taro
    Kakizawa, Nao
    Watanabe, Fumiaki
    Kikugawa, Rina
    Hasegawa, Fumi
    Tsujinaka, Shingo
    Miyakura, Yasuyuki
    Konishi, Fumio
    Rikiyama, Toshiki
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (04)
  • [43] Association of FcgRIIa and FcgRIIIa polymorphisms and kras mutations with clinical outcome in patients with metastatic colorectal cancer treated with cetuximab plus irinotecan
    Bibeau, F.
    Crapez, E.
    Di Fiore, F.
    Thezenas, S.
    Sabourin, J.
    Lamy, A.
    Frebourg, T.
    Michel, P.
    Ychou, M.
    Boissiere, F.
    ANNALS OF ONCOLOGY, 2008, 19 : 27 - 27
  • [44] Detection of KRAS Oncogene in Peripheral Blood as a Predictor of the Response to Cetuximab Plus Chemotherapy in Patients with Metastatic Colorectal Cancer
    Yen, Li-Chen
    Yeh, Yung-Sung
    Chen, Chao-Wen
    Wang, Hwei-Ming
    Tsai, Hsiang-Lin
    Lu, Chien-Yu
    Chang, Yu-Tang
    Chu, Koung-Shing
    Lin, Shiu-Ru
    Wang, Jaw-Yuan
    CLINICAL CANCER RESEARCH, 2009, 15 (13) : 4508 - 4513
  • [45] Clinical relevance of circulating KRAS mutated DNA in plasma from patients with advanced pancreatic cancer
    Tjensvoll, Kjersti
    Lapin, Morten
    Buhl, Tove
    Oltedal, Satu
    Berry, Katrine Steen-Ottosen
    Gilje, Bjornar
    Soreide, Jon Arne
    Javle, Millind
    Nordgard, Oddmund
    Smaaland, Rune
    MOLECULAR ONCOLOGY, 2016, 10 (04) : 635 - 643
  • [46] Durable responses to TAS-102 plus bevacizumab and TACE in salvage-line treatment of KRAS-mutated and MSS metastatic colorectal cancer: a case report
    Zhao, Wensi
    Song, Jian
    AMERICAN JOURNAL OF TRANSLATIONAL RESEARCH, 2023, 15 (07): : 4805 - 4812
  • [47] Association of somatic KRAS gene mutations and clinical outcome in patients (pts) with metastatic colorectal cancer (mCRC) receiving panitumumab monotherapy
    Freeman, D.
    Juan, T.
    Meropol, N. J.
    Hecht, J. R.
    Berlin, J.
    Van Cutsem, E.
    Reiner, M.
    Radinsky, R.
    Amado, R. G.
    Peeters, M.
    EJC SUPPLEMENTS, 2007, 5 (04): : 239 - 239
  • [48] Comparison of methods for measuring total cell-free DNA and KRAS mutations in plasma from metastatic colorectal cancer patients
    Demuth, C.
    Spindler, K. -L. G.
    Johansen, J. S.
    Pallisgaard, N.
    Nielsen, D.
    Hoegdall, E.
    Vittrup, B.
    Sorensen, B.
    ANNALS OF ONCOLOGY, 2016, 27 : 2 - 3
  • [49] Prognostication of Metastatic Colorectal Cancer by Circulating Tumor DNA Levels in Serum as a Predictor of Response to Chemotherapy
    Younus, Shifa
    Ali, Kashif
    Shabbir, Usama B.
    Gulraiz, Azouba
    Hussain, Alamdar
    Cheema, Muhammad Hassan
    Cheema, Muhammad Hussnain
    Saleem, Hamza
    Choudhary, Humais H.
    Rani, Anmol
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2024, 119 (10S): : S238 - S238
  • [50] Association KRAS G13D Tumor Mutated Outcome in Patients with Chemotherapy Refractory Metastatic Colorectal Cancer Treated with Cetuximab
    Tural, Deniz
    Selcukbiricik, Fatih
    Erdamar, Sibel
    Ozkurt, Canan Unlu
    Yanmaz, Teoman
    Mandel, Nil Molinas
    Serdengecti, Suheyla
    HEPATO-GASTROENTEROLOGY, 2013, 60 (125) : 1035 - 1040
12345